Publications by authors named "Samir Arora"

Claim this Profile
I
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
Elena A Christofides, Orlando Puente, Paul Norwood, Douglas Denham, Hiralal Maheshwari, Samir Arora

Diabetes Obes Metab· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial.
Joseph A Murray, Dina Wassaf, Karen Dunn, Samir Arora, Peter Winkle

Lancet Gastroenterol Hepatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.
Timo Vesikari, Adam Finn, Pierre van Damme, Isabel Leroux-Roels, Geert Leroux-Roels, Samir Arora

JAMA Netw Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do we need more patient-friendly treatment options for overactive bladder (OAB)?
Nel Gerig, Tracy Cameron, Samir Arora, Jessica Spear, Laura Lescozec

Neurourol Urodyn· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.
Fernando J Martinez, Klaus F Rabe, Brian J Lipworth, Samir Arora, Martin Jenkins

Int J Chron Obstruct Pulmon Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA.
Brian J Lipworth, David J Collier, Yasuhiro Gon, Nanshan Zhong, Koichi Nishi, Samir Arora

Int J Chron Obstruct Pulmon Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration.
Samir Arora, Betsy Moclair, Kyle Murphy, Jonathan S Jaffe, Jed C Kaminetsky

J Sex Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD.
Edward M Kerwin, Thomas M Siler, Samir Arora, Patrick Darken, Earl Rose

Int J Chron Obstruct Pulmon Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD.
Colin Reisner, Gregory Gottschlich, Faisal Fakih, Andras Koser, James Krainson, Samir Arora

Respir Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD.
Fernando J Martinez, Klaus F Rabe, Gary T Ferguson, Leonardo M Fabbri, Stephen Rennard, Samir Arora

Chest· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
Samir Arora, Beatrice Setnik, Drass Michael, John D Hudson, Ray Clemmer

J Opioid Manag· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis